Alnylam Pharmaceuticals (ALNY) Non-cash Items (2010 - 2018)

Alnylam Pharmaceuticals has reported Non-cash Items for 9 years, with the latest figure at $23.7 million in Q4 2018.

• For the quarter ending Q4 2018, Non-cash Items rose 347.56% year-over-year to $23.7 million; the trailing twelve-month figure through Dec 2018 stood at $23.7 million (up 347.56% YoY), and the FY2018 full-year result was $23.7 million, up 347.56% from the prior year.
• Non-cash Items for Q4 2018 stood at $23.7 million, up from $5.3 million in the prior quarter.
• The five-year high for Non-cash Items was $352.6 million in Q4 2015, with the low at $4.7 million in Q4 2014.
• Historically, Non-cash Items has averaged $90.2 million across 5 years, with a median of $23.7 million in 2018.
• Annual changes were most pronounced in 2015 — Non-cash Items soared 7346.07% — and 2017, when it sank 91.82%.
• Alnylam Pharmaceuticals' Non-cash Items stood at $4.7 million in 2014, then soared by 7346.07% to $352.6 million in 2015, then tumbled by 81.64% to $64.8 million in 2016, then slumped by 91.82% to $5.3 million in 2017, then surged by 347.56% to $23.7 million in 2018.
• The last three Non-cash Items figures came in at $23.7 million (Q4 2018), $5.3 million (Q4 2017), and $64.8 million (Q4 2016), per Business Quant data.